| Effects of valsartan on diabetic cardiomyopathy in rats with type 2 diabetes mellitus. | |
| | |
MedLine Citation:
|
PMID: 22166644 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
BACKGROUND: The development of diabetic cardiomyopathy is multifactorial. Insulin resistance (IR) and excessive activity of the renin-angiotensin system are confirmed reasons for diabetic cardiomyopathy. Renin-angiotensin system (RAS) inhibitors can reduce tissue Ang II levels, with beneficial effects on cardiovascular function. Therefore, in type-2 diabetes mellitus (T2DM), blockade of the RAS may have the function of protecting against diabetic cardiomyopathy through increasing insulin sensitivity and inhibiting excessive activity of RAS. However, this has not been confirmed. METHODS: The effect of valsartan, an angiotensin receptor blocker (ARB), on diabetic cardiomyopathy in the presence of T2DM was studied. Wistar rats with T2DM and T2DM treated with valsartan were studied. Glucose infusion rates (GIR), index of IR, heart weight, the heart weight-to-body weight ratio (HW/BW), myocardial apoptotic index, cardiac hydroxyprolin content, and cardiac tissue collagen type I and collagen type III content were measured. RESULTS: GIR in T2DM rats and T2DM rats treated with valsartan decreased (P < 0.01). In T2DM rats treated with valsartan, heart weight, myocardial apoptotic index, cardiac hydroxyprolin content, and cardiac tissue collagen type I and collagen type III content were higher than in control rats, but lower than in T2DM rats. In rats with T2DM, GIR was negatively and significantly correlated with all the variables. However, in T2DM rats treated with valsartan or normal control rats, none of the correlations was significant. CONCLUSIONS: In the presence of T2DM, diabetic cardiomyopathy is related with IR. Valsartan can not alleviate IR, but can protect against diabetic cardiomyopathy and remove the correlation between IR and diabetic cardiomyopathy. |
| | |
Authors:
|
Zhong-Hua Yang; Xiao-Dong Peng |
Related Documents
:
|
7882604 - Effects of erythropoietin on glucose tolerance in hemodialysis patients. 3315764 - Role of alpha and beta cells in the impaired glucose tolerance of thalassaemic subjects. 1862694 - The effects of bilio-jejunal diversion on streptozotocin diabetes in the rat. 22234664 - Arthroplasty in veterans: analysis of cartilage, bone, serum, and synovial fluid reveal... 19817794 - Role and therapeutic potential of micrornas in diabetes. 15205554 - Pentoxifylline ameliorates renal tumor necrosis factor expression, sodium retention, an... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Chinese medical journal Volume: 123 ISSN: 0366-6999 ISO Abbreviation: Chin. Med. J. Publication Date: 2010 Dec |
Date Detail:
|
Created Date: 2011-12-14 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7513795 Medline TA: Chin Med J (Engl) Country: China |
Other Details:
|
Languages: eng Pagination: 3640-3 Citation Subset: IM |
Affiliation:
|
Department of Geriatrics, West China Hospital, West China Medical Hospital of Sichuan University, Chengdu, Sichuan 610041, China (Email: 417354278@qq.com). |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Transforming growth factor-?1 involved in urotensin II-induced phenotypic differentiation of adventi...
Next Document: Application of anti-CD103 immunotoxin for saving islet allograft in context of transplantation.